A new trading day began on Tuesday, with Clearside Biomedical Inc (NASDAQ: CLSD) stock price up 7.69% from the previous day of trading, before settling in for the closing price of $0.4. CLSD’s price has ranged from $0.29 to $1.65 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 10.40% over the last five years. Meanwhile, its annual earnings per share averaged 37.39%. With a float of $61.99 million, this company’s outstanding shares have now reached $78.50 million.
The firm has a total of 32 workers. Let’s measure their productivity. In terms of profitability, gross margin is 88.45%, operating margin of -524.63%, and the pretax margin is -648.03%.
Clearside Biomedical Inc (CLSD) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Clearside Biomedical Inc is 21.04%, while institutional ownership is 14.26%. The most recent insider transaction that took place on Feb 24 ’25, was worth 13,800. In this transaction Director of this company bought 15,000 shares at a rate of $0.92, taking the stock ownership to the 176,141 shares. Before that another transaction happened on Nov 01 ’24, when Company’s Chief Medical Officer bought 36,500 for $1.00, making the entire transaction worth $36,500. This insider now owns 100,000 shares in total.
Clearside Biomedical Inc (CLSD) Earnings and Forecasts
In its latest quarterly report, released on 9/30/2024, the company reported earnings of -0.1 per share, which was $0.1 higher than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.04 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 37.39% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 30.91% during the next five years compared to 10.40% growth over the previous five years of trading.
Clearside Biomedical Inc (NASDAQ: CLSD) Trading Performance Indicators
Here are Clearside Biomedical Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.17.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.36, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.27 in one year’s time.
Technical Analysis of Clearside Biomedical Inc (CLSD)
Analysing the last 5-days average volume posted by the [Clearside Biomedical Inc, CLSD], we can find that recorded value of 0.5 million was lower than the volume posted last year of 1.93 million. As of the previous 9 days, the stock’s Stochastic %D was 36.16%.
During the past 100 days, Clearside Biomedical Inc’s (CLSD) raw stochastic average was set at 18.61%, which indicates a significant decrease from 30.77% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0578 in the past 14 days, which was lower than the 0.0629 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6689, while its 200-day Moving Average is $0.8791. Now, the first resistance to watch is $0.4585. This is followed by the second major resistance level at $0.4830. The third major resistance level sits at $0.5160. If the price goes on to break the first support level at $0.4010, it is likely to go to the next support level at $0.3680. Should the price break the second support level, the third support level stands at $0.3435.
Clearside Biomedical Inc (NASDAQ: CLSD) Key Stats
With a market capitalization of 34.07 million, the company has a total of 78,510K Shares Outstanding. Currently, annual sales are 1,660 K while annual income is -34,350 K. The company’s previous quarter sales were 490 K while its latest quarter income was -4,500 K.
